Respiratory

Understand respiratory symptoms and function beyond clinic visits

See how breathlessness, cough, exacerbations, activity, sleep, and treatment experience change day to day in asthma, COPD, and other respiratory conditions, including environmental triggers.

AT A GLANCE
14K
people with asthma enrolled for a top pharma company
1 week
to enroll them, all eligible and consented
ACT & CAT
validated control and impact assessments
PM2.5
and ozone linked by location and date

Respiratory disease burden happens between visits

Symptoms shift with season, air quality, infections, and adherence, and many exacerbations are managed at home and never fully recorded.

The gap

What today's data miss

  • How exacerbations build, peak, and resolve between visits
  • How activity, sleep, and breathlessness change around a flare
  • How controller and rescue medication are used in daily life
  • Who stays uncontrolled despite treatment, and why

Open questions

What life sciences teams are asking

  • What does an exacerbation look like before it's treated?
  • How quickly do activity, sleep, and symptoms recover?
  • How do air quality, pollen, and temperature relate to flares?
  • Who may be a candidate for escalation, and what holds them back?

Our approach

Respiratory disease in daily life

  • Longitudinal tracking of symptoms, exacerbations, and recovery
  • Wearable signals alongside ACT and CAT questionnaires
  • Event-triggered surveys at flares or unscheduled care
  • Linkage to local weather and air-quality data

Data for a better understanding of respiratory conditions

Continuous, direct engagement captures longitudinal data across symptoms, behavior, and environment.

Who patients are
  • Age, sex, gender identity, race and ethnicity
  • Income, education, employment, household
  • Insurance, out-of-pocket costs, affordability
  • Access barriers: transportation, food, care
What they experience
  • Daily breathlessness, cough, wheeze, sleep disruption
  • Validated instruments (ACT, CAT, mMRC)
  • Exacerbations and recovery in near real time
What they do
  • Activity, sleep, and resting heart rate
  • Work, exercise tolerance, and daily function
  • Controller and rescue-inhaler use
Treatment experience
  • Medication history, persistence, adherence
  • Switching, escalation, and reported response
  • Inhaler technique, side effects, burden
Environment
  • Air quality (PM2.5, ozone) by location and date
  • Temperature, humidity, and seasonality
  • Infection seasons and community illness
Variation in burden
  • Differences in control and exacerbation frequency
  • Variability in response and recovery
  • Impact on quality of life and function
Clinical data
  • Diagnoses, comorbidities, spirometry or labs (EHR)
  • Emergency visits, hospitalizations, specialists
  • Healthcare utilization across settings
Real-world outcomes
  • Exacerbation patterns and recovery
  • Functional impact and quality of life
  • Long-term control and persistence
Trusted by leading life sciences companies:

Inside a respiratory study

How a top pharma company assembled a large asthma cohort on schedule.

14K
people with asthma recruited in one week
1 wk
from targeted in-app outreach to enrolled, consented cohort
U.S.
adults in the Evidation Community with self-reported asthma

Study design

Question

Can a large, well-characterized asthma cohort be assembled fast enough to keep a program on schedule?

Design

Targeted in-app outreach, digital eligibility screening, and eConsent.

Data

Screening survey, symptom-control questionnaire, and wearable data where shared.

Outcome

About 14,000 eligible, consented participants enrolled within one week.

Real-world insights in respiratory health

Research, webinars, and news from our work with people living with respiratory conditions.

Let's design your next study

Tell us the question you need to answer. Our scientists will show you which cohorts, data types, and study designs can get you there, and how quickly.